MARCY-L’ÉTOILE, France, Feb. 18, 2026 /PRNewswire/ — bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™,MARCY-L’ÉTOILE, France, Feb. 18, 2026 /PRNewswire/ — bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™,

bioMérieux launches SMARTBIOME™ to help food manufacturers gain deeper insights into spoilage and protect product quality

2026/02/18 23:01
Okuma süresi: 4 dk

MARCY-L’ÉTOILE, France, Feb. 18, 2026 /PRNewswire/ — bioMérieux, a world leader in the field of in vitro diagnostics, today announces the launch of SMARTBIOME™, an innovative solution designed to help food manufacturers better understand, control and prevent microbiological spoilage. By combining highprecision DNA sequencing, advanced bioinformatics and bioMérieux’s microbiology expertise, SMARTBIOME™ provides actionable insights to protect product quality, reduce waste and better preserve consumer safety.

Every year, microbial spoilage contributes significantly to food waste and quality losses across the global food industry. Scientific estimates indicate that 15–20% of food is wasted after production, and part of the waste is due to spoilage, with microorganisms such as Pseudomonas, aerobic and anaerobic spore‑formers, and fungi playing a major role in both fresh and processed foods and beverages.1

For food manufacturers, these challenges lead to substantial economic losses, reputational risks and operational disruption. Identifying the microorganisms responsible for spoilage, understanding their origin and preventing recurrence remain complex and time‑consuming tasks.

SMARTBIOME™ addresses these challenges through an advanced, accessible platform for in-depth spoilage investigation. The solution combines high‑resolution DNA sequencing with powerful bioinformatics and data science, an exclusive spoilage knowledge base, and bioMérieux’s expert consulting services. Together, these capabilities transform complex microbiological data into clear, actionable insights.

Spot spoilage, act confidently and prevent contamination

The solution enables food manufacturers to accurately identify spoilage organisms at every stage of production, trace issues back to their root cause using data‑driven insights and strengthen process controls. By monitoring microbiological trends over time, manufacturers can anticipate risks and proactively adjust their processes to prevent future spoilage events before they escalate. 

“With SMARTBIOME™, we are giving food manufacturers the ability to understand and control spoilage like never before,” declared Alejo Migones, Senior Vice President, Food Safety & Quality. “By combining our microbiology expertise with powerful data science, we continue to enhance our Augmented Diagnostics approach by helping our customers run healthy and sustainable operations.” 

This innovative solution has been developed in close collaboration with the teams of Neoprospecta, a Brazil‑based genomics and data science company acquired by bioMérieux in January 2025. The teams jointly work in establishing an international reference in technologies and solutions for microorganism analysis, identification and control.

“Through the development of sequencing and datadriven microbiology solutions, we move beyond isolated test results to deliver meaningful, actionable insights. This allows us to support food manufacturers more effectively, helping them improve processes and making bioMérieux a true longterm partner in their microbiological risk management and quality programs. Ultimately, these advances also contribute to delivering safer products to consumers,” added Yasha Mitrotti, Executive Vice President, Industrial Applications, bioMérieux.

SMARTBIOME™ is already available for food manufacturers in several regions worldwide, including North America, Latin America and Europe.

1 Snyder, A.B., Martin, N. & Wiedmann, M. Microbial food spoilage: impact, causative agents and control strategies. Nat Rev Microbiol 22, 528–542 (2024). https://doi.org/10.1038/s41579–024–01037–x  

ABOUT BIOMÉRIEUX
Pioneering Diagnostics
A world leader in the field of in vitro diagnostics since 1963, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2024, revenues reached €4 billion, with over 93% of sales outside of France. 

bioMérieux provides diagnostic solutions (systems, reagents, software and services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in  agri-food, pharmaceutical and cosmetic products. www.biomerieux.com.  

bioMérieux is listed on the Euronext Paris stock market. 
Symbol: BIM – ISIN Code: FR0013280286
              Reuters: BIOX.PA/Bloomberg: BIM.FP 

CONTACTS
Investors Relations 
Aymeric Fichet
Tel: +33 (0)4 78 87 20 00                   

investor.relations@biomerieux.com

Media Relations  

Corporate                                 

United States    

France

Romain Duchez

Todd Siesky                       

Isabelle de Segonzac (Image 7) 

Tel: +33 (0)4 78 87 20 00

Tel: +1 919.791.5822

Tel: +33 (0)1 53 70 74 85 

media@biomerieux.com 

todd.siesky@biomerieux.com           

lheilbronn@image7.fr 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biomerieux-launches-smartbiome-to-help-food-manufacturers-gain-deeper-insights-into-spoilage-and-protect-product-quality-302689937.html

SOURCE bioMérieux

Piyasa Fırsatı
Griffin AI Logosu
Griffin AI Fiyatı(GAIN)
$0.002046
$0.002046$0.002046
0.00%
USD
Griffin AI (GAIN) Canlı Fiyat Grafiği
Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen service@support.mexc.com ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Protectt.ai Launches New Version of Its AI & Behaviour-Driven Mobile App Security Platform, AppProtectt, in Dubai

Protectt.ai Launches New Version of Its AI & Behaviour-Driven Mobile App Security Platform, AppProtectt, in Dubai

DUBAI, United Arab Emirates–(BUSINESS WIRE)–#AIRedTeaming–Protectt.ai, a global AI-native Mobile App Security and Fraud Control platform, today announced in Dubai
Paylaş
AI Journal2026/02/19 00:17
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Paylaş
BitcoinEthereumNews2025/09/18 00:56
Pi Network and the Global Rules: How KYC and KYB Are Shaping the Digital Economy

Pi Network and the Global Rules: How KYC and KYB Are Shaping the Digital Economy

Pi Network and the Global Rules: KYC and KYB as Passports to the Digital Economy The cryptocurrency landscape is evolving rapidly, and Pi Network is at the fore
Paylaş
Hokanews2026/02/19 00:44